Frederic Jeannot

Title: Inventor Frederic Jeannot: Pioneering Innovations in Kinase Inhibitors

Introduction

Frederic Jeannot, a distinguished inventor based in Paris, France, has made significant contributions to the field of pharmaceuticals through his innovative work on kinase inhibitors. With a total of two patents to his name, his research focuses on developing compounds that address critical health issues, particularly those related to diabetes and its complications.

Latest Patents

Frederic Jeannot's latest patents showcase his dedication to advancing medical science. His first patent involves "6-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors." This invention relates to pyrazolo[3,4-b]pyridine compounds that serve as kinase inhibitors, targeting diseases associated with diabetes and its complications, including diabetic nephropathy, neuropathy, and retinopathy. The compounds in this formula are particularly noted for their potential use as active ingredients in pharmaceuticals.

The second patent is centered around "Substituted isoquinolines and isoquinolinones as Rho kinase inhibitors." This invention covers substituted isoquinoline and isoquinolinones that are beneficial in the treatment and prevention of diseases linked to Rho-kinase and its mediation of myosin light chain phosphatase phosphorylation.

Career Highlights

Frederic Jeannot currently works with Sanofi, a leading global pharmaceutical company. His role has allowed him to focus on groundbreaking research while contributing to the development of effective medical treatments. Jeannot's innovative spirit and commitment to science have positioned him as a notable figure in the field of pharmaceutical research.

Collaborations

Throughout his career, Frederic Jeannot has collaborated with esteemed colleagues such as Oliver Plettenburg and Matthias Loehn. These partnerships highlight the importance of teamwork in advancing research and bringing innovative solutions to market.

Conclusion

Frederic Jeannot's impactful inventions in kinase inhibitors illustrate his commitment to addressing significant health challenges. Through his patents, he not only furthers the field of pharmaceuticals but also helps pave the way for new treatments that can significantly improve the lives of individuals suffering from diabetic complications. His work serves as an inspiration to fellow inventors and researchers in the global scientific community.